Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Ashco Niulab Industries Ltd (ASHCONIUL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517565 NSE: ASHCONIUL Electronics - Components | Small Cap | Ashco Niulab Inds Share Price
BSE Share Price
Not Listed
Not Listed
Ashco Niulab Industries Ltd (ASHCONIUL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517565 NSE: ASHCONIUL Electronics - Components | Small Cap | Ashco Niulab Inds Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹2 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-0.2
TTM Sales
₹82.2 Cr.
Book Value per Share
₹13.3
P/E Ratio
0.00
Industry PE
49.2
Price to Book (P/B)
0.02
Price to Sales (P/S)
0.02
EV/EBITDA
3.74
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
3.54%
Return on Capital Employed (ROCE)
9.47%
Return on Assets (ROA)
1.68%
Operating Profit Margin
9.6%
Net Profit Margin
1.21%
Gross Profit Margin
5.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-54.09%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
59.92%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
9.06%
Pledged shares (%) of Promoter's holding (%)
8.49%
Reserves
₹21 Cr.
Equity
₹65 Cr.
Face Value
₹10
All Time Low / High
₹0.21 / 98.17
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Sep'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 9.8% | 8.6% | 11.4% | 14% | 14.7% | 13.8% | 6.8% | 6.5% | -5.9% | -2.7% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 27.3 | 29.9 | 35.2 | 38.6 | 40.7 | 35 | 51.7 | 82.2 | 80.4 | 36.9 | 40 |
| Sales YoY Gr. | - | 9.9% | 17.5% | 9.8% | 5.3% | -14% | 47.8% | 59% | -2.3% | -54.1% | - |
| Adj EPS ⓘ | 0.5 | 0.7 | 0.9 | 1.1 | -0.7 | 1.3 | -1.4 | -0.3 | -1.4 | -2.8 | -1.5 |
| YoY Gr. | - | 38% | 29% | 24.7% | -159.5% | NA | -208.7% | NA | NA | NA | - |
| BVPS (₹) ⓘ | 10.9 | 10.8 | 11.4 | 12.7 | 14.3 | 14.4 | 13.5 | 10.9 | 7.3 | 20.1 | 10.2 |
| Adj Net Profit ⓘ | 0.6 | 0.8 | 1.1 | 1.3 | -0.8 | 1.5 | -1.7 | -1.1 | -9.1 | -18.2 | -9 |
| Cash Flow from Ops. ⓘ | -0.8 | -0.3 | -0.1 | 6.4 | -2.6 | -2.9 | 14.3 | 4.7 | -25 | 5.8 | - |
| Debt/CF from Ops. ⓘ | -11 | -27.2 | -178.6 | 3.1 | -7.7 | -9.3 | 2.6 | 7.6 | -1.1 | 12.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 3.4% | -1.9% | -10.6% | -54.1% | ||||
| Adj EPS ⓘ | -221.1% | NA | NA | NA | ||||
| BVPSⓘ | 7.1% | 7.1% | 14.3% | 176.3% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Sep'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 4.7 | 6.3 | 8 | 9.2 | -4.9 | 8.8 | -6.3 | -3.1 | -26 | -13.3 | -9.6 |
| Op. Profit Mgn % ⓘ | 8.2 | 7.1 | 11.6 | 15.5 | 9.6 | 24.3 | -34 | 12.9 | 1.9 | -16.3 | 7.7 |
| Net Profit Mgn % ⓘ | 2.2 | 2.8 | 3 | 3.4 | -2 | 4.3 | -3.2 | -1.3 | -11.4 | -49.3 | -23.7 |
| Debt to Equity ⓘ | 0.7 | 0.7 | 1.1 | 1.3 | 1.1 | 1.5 | 2.3 | 1 | 0.6 | 0.6 | - |
| Working Cap Days ⓘ | 264 | 251 | 255 | 229 | 238 | 379 | 358 | 272 | 252 | 2,073 | 329 |
| Cash Conv. Cycle ⓘ | 85 | 64 | 51 | 58 | 107 | 173 | 236 | 123 | 90 | 686 | 246 |
Valuation of Ashco Niulab Inds - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.49 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'10 | Sep'11 |
|---|---|---|---|---|---|---|---|---|
| Sales | 25.33 | 27.30 | 30.02 | 35.36 | 38.74 | 40.77 | 82.22 | 176.57 |
| Operating Expenses ⓘ + | 22.76 | 25.04 | 28.17 | 31.28 | 32.73 | 36.85 | 71.63 | 159.65 |
| Operating Profit ⓘ | 2.58 | 2.26 | 1.85 | 4.08 | 6.01 | 3.93 | 10.58 | 16.92 |
| Operating Profit Margin (%) | 10.2% | 8.3% | 6.2% | 11.5% | 15.5% | 9.6% | 12.9% | 9.6% |
| Other Income ⓘ + | 0.43 | 0.95 | 1.04 | 0.04 | 0.33 | 3.90 | 0.14 | 1.91 |
| Interest ⓘ | 1.45 | 1.51 | 1.32 | 1.44 | 1.85 | 2.27 | 4.51 | 8.62 |
| Depreciation ⓘ | 1.06 | 1.08 | 0.97 | 1.23 | 1.91 | 2.56 | 6.14 | 9.55 |
| Profit Before Tax ⓘ | 0.50 | 0.62 | 0.59 | 1.45 | 2.58 | 3 | 0.08 | 0.67 |
| Tax ⓘ | 0.11 | 0.01 | -0.03 | 0.38 | 1.03 | 1.08 | 1.12 | -1.46 |
| Profit After Tax | 0.39 | 0.61 | 0.62 | 1.06 | 1.55 | 1.92 | -1.04 | 2.13 |
| PAT Margin (%) | 1.5% | 2.2% | 2.1% | 3.0% | 4.0% | 4.7% | -1.3% | 1.2% |
| Adjusted EPS (₹) | 0.3 | 0.5 | 0.5 | 0.9 | 1.3 | 1.6 | -0.3 | 0.3 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 28.20% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'10 | Sep'11 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 12.56 | 13.18 | 13.08 | 13.80 | 15.36 | 17.28 | 34.09 | 86.36 | |||
| Debt + | 8.92 | 9.06 | 9.32 | 14.64 | 19.56 | 19.66 | 35.62 | 40.17 | |||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Trade Payables | 3 | 4.37 | 5.10 | 8.98 | 3.59 | 12.42 | 12.91 | 35.38 | |||
| Others Liabilities ⓘ | 3.66 | 1.90 | 1.38 | 1.98 | 2.55 | 3.50 | 8.13 | 0.74 | |||
| Total Liabilities ⓘ | 28.16 | 28.50 | 28.88 | 39.40 | 41.05 | 52.85 | 90.75 | 162.65 | |||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 7.48 | 6.75 | 7 | 10.47 | 18.14 | 18.12 | 28.06 | 24.74 | |||
| CWIP ⓘ | 0.19 | 0.34 | 0 | 0 | 1.15 | 1.49 | 0 | 0.04 | |||
| Investments ⓘ | 0 | 0.01 | 0.01 | 0 | 0 | 0.03 | 0.88 | 0.04 | |||
| Inventories | 4.24 | 4.67 | 5.53 | 6.33 | 5.78 | 15.44 | 21.10 | 53.33 | |||
| Trade Receivables | 7.12 | 5.02 | 5.73 | 9.35 | 7.07 | 9.77 | 17.89 | 74.92 | |||
| Cash Equivalents | 1.07 | 1.07 | 0.69 | 0.79 | 1.12 | 0.55 | 0.72 | 1.97 | |||
| Others Assets ⓘ | 8.06 | 10.64 | 9.92 | 12.45 | 7.79 | 7.45 | 22.11 | 7.60 | |||
| Total Assets ⓘ | 28.16 | 28.50 | 28.88 | 39.40 | 41.05 | 52.85 | 90.75 | 162.65 | |||
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'10 | Sep'11 |
|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0.82 | -0.83 | -0.33 | -0.07 | 6.35 | -4.04 | 4.68 | -37.22 |
| Cash Flow From Investing Activity ⓘ + | -1.43 | 0.44 | -0.11 | -4.66 | -10.71 | 0.99 | -0.17 | -3.78 |
| Cash Flow From Financing Activity ⓘ + | 0.70 | 0.38 | 0.06 | 4.83 | 4.69 | 2.49 | -4.96 | 42.25 |
| Net Cash Flow ⓘ | 0.10 | -0.01 | -0.38 | 0.10 | 0.33 | -0.57 | -0.45 | 1.25 |
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'10 | Sep'11 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 3.13 | 4.79 | 4.77 | 7.93 | 10.62 | 11.74 | -4.04 | 3.54 | ||
| ROCE (%) | 9.11 | 9.77 | 8.62 | 11.37 | 13.97 | 14.66 | 8.6 | 9.47 | ||
| Asset Turnover Ratio | 0.9 | 0.96 | 1.05 | 1.04 | 0.96 | 0.87 | 1.15 | 1.39 | ||
| PAT to CFO Conversion(x) | 2.1 | -1.36 | -0.53 | -0.07 | 4.1 | -2.1 | N/A | -17.47 | ||
| Working Capital Days | ||||||||||
| Receivable Days | 102.50 | 81.10 | 65.40 | 77.80 | 77.30 | 75.40 | 61.40 | 95.90 | ||
| Inventory Days | 61.10 | 59.60 | 62 | 61.20 | 57.10 | 95 | 81.10 | 76.90 | ||
| Payable Days | 75.50 | 78.60 | 87.60 | 126.20 | 106.20 | 102.30 | 87.10 | 70.30 | ||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Ashco Niulab Industries Ltd FAQs
The current trading price of Ashco Niulab Inds on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ashco Niulab Inds stood at ₹1.88 Cr
The latest P/E ratio of Ashco Niulab Inds as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Ashco Niulab Inds as of 31-Dec-1969 is 0.03.
The 52-week high of Ashco Niulab Inds is ₹0.29 and the 52-week low is ₹0.26.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ashco Niulab Inds is ₹39.77 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Ashco Niulab Industries Ltd
Ashco Niulab Industries incorporated in the year 1986. Ashok K. Kotwani initiated the first company of the group, Niulab Equipment Company Pvt Ltd. in 1982, followed by Ashco industries Ltd. in 1986 and now renamed as Ashco Niulab Industries Ltd. From a small beginning, today the group has more than 250 employees and national presence with corporate headquarters in Mumbai, 14 branches, 4 laboratories and an office in USA. The company’s corporate office is located at Lab House, Plot No F - 13, Opp. Seepz, Andheri E Mumbai, Maharashtra-400093 .
The company provides services to all major pharmaceuticals and FMCG companies. For international business the company is focusing in US, Europe, Latin America and other overseas markets. In order to facilitate US operations the company has office in New Jersey. The company provides with the services of Contract Research (BA/BE), Analytical Services, Process Safety Lab and Instrumentation.
Contract Research (BA/BE) - Spread over 20,000 sq.ft, the company provides contract research services in areas of bioavailability and bioequivalence studies. It delivers cost effective, timely research solutions to the Pharmaceutical and Biotechnology companies’ world wide. It offers its clients significant value addition that includes quicker subject/special population recruitment, quality assurance and competitive cost.
Analytical Services - In the technologically advance times of today, leading edge R & D is a pre-condition to success. Various manufacturing organizations require Analytical solutions which need the outsourced support of sophisticated equipment and skilled professionals, to develop new products or for quality checks. The company provides support to organizations through state-of-art infrastructure and well qualified and experienced professionals. The company is already providing analytical solutions to various industries like pharmaceuticals, food and environmental studies. The company strives to provide quality services at all times to their esteemed clientele through their team of dedicated professionals. Three strategically located laboratories at Mumbai, Noida and Hyderbad, enable it to cater to the analytic needs across the country. The company’s laboratories are accredited by NABL, local FDAs, DGCA and ISO.
Process Safety Lab - The company provide solutions to the industry for process optimisation and process safety. Ashco Niulab Industries provides solutions to pharma and chemical industries. The company will be installing Reaction Calorimeter and Thermal Scanning Calorimeter to provide right solution. To the industry Ashco Niulab Industries will also organize training on process safety and product safety.
Instrumentation - The company’s instrumentation division provides solutions to industry for Pharma Chemical R & D, & Quality control. From their principals from Switzerland, France, Japan, USA.
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
